Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial.
Gharbharan A, Jordans C, Zwaginga L, Papageorgiou G, van Geloven N, van Wijngaarden P, den Hollander J, Karim F, van Leeuwen-Segarceanu E, Soetekouw R, Lammers J, Postma D, Kampschreur L, Groeneveld G, Swaneveld F, van der Schoot CE, Götz H, Haagmans B, Koopmans M, Bogers S, Geurtsvankessel C, Zwaginga JJ, Rokx C, Rijnders B; CoV-Early study group.
Gharbharan A, et al. Among authors: van leeuwen segarceanu e, van wijngaarden p, van der schoot ce, van geloven n.
Clin Microbiol Infect. 2023 Feb;29(2):208-214. doi: 10.1016/j.cmi.2022.08.005. Epub 2022 Aug 23.
Clin Microbiol Infect. 2023.
PMID: 36007870
Free PMC article.
Clinical Trial.